vitiligo

How to Diagnose and Treat Hypopigmentation with Dr. Hamzavi
hypopigmentationNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Iltefat Hamzavi, dermatologist with Henry Ford Health and associate professor of dermatology at Wayne State University School of Medicine. Dr. Hamzavi addresses how to diagnose and treat hypopigmentation, a catch-all for pigmentary conditions where the pigment is not too dark or complete …
hypopigmentation
Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
Tofacitinib INTRODUCTION Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib …
Tofacitinib
Thyroid Dysfunction – Friday Pop Quiz 1/13/2023
What mutation is responsible for this clinical presentation in a patient with both thyroid dysfunction and chronic candidal infections? A. Autoimmune regulator (AIRE) B. Phosphatase and tensin homolog (PTEN) C. Tyrosine related protein 1 (TRP1) D. Fumarate hydratase (FH) E. Lysosomal trafficking regulator (LYST)   To find out the correct answer and read the explanation, …